# JAMA

Source: https://onco.cc/journals/jama/  
OnCo record `jama` (Journal). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

JAMA is the American Medical Association's flagship journal. It is strong on cancer screening, prevention, health-services and patient-reported-outcome research, and on the USPSTF recommendations.

## Summary

JAMA is a weekly general-medicine journal. In oncology it carries screening and prevention trials, the US Preventive Services Task Force recommendation statements, health-policy and drug-pricing analyses, and landmark care-delivery studies such as Basch's 2017 electronic symptom-monitoring survival result. Hybrid access; research articles are free to read after 12 months.

## Fields

- Kind: Journal
- Last checked: 2026-09-09
- Also known as: Journal of the American Medical Association; JAMA
- Publisher: American Medical Association (JAMA Network)
- Scope: general medicine
- Access: hybrid

## Sources

- Wikipedia: https://en.wikipedia.org/wiki/JAMA
- JAMA Network oncology: https://jamanetwork.com/collections/5644/oncology

## Connected records

- collections: [PubMed & Europe PMC](https://onco.cc/collections/pubmed-europepmc/)
- key papers: [AALL1331: blinatumomab versus chemotherapy consolidation in high- and intermediate-risk first relapse of childhood B-ALL](https://onco.cc/key-papers/paper-aall1331-brown-jama-2021/), [Active Monitoring With or Without Endocrine Therapy for Low-Risk Ductal Carcinoma In Situ: The COMET Randomized Clinical Trial](https://onco.cc/key-papers/paper-comet-dcis-jama-2025/), [Adjuvant chemotherapy with gemcitabine vs observation in patients undergoing curative-intent resection of pancreatic cancer: a randomized controlled trial](https://onco.cc/key-papers/paper-conko-001-adjuvant-gemcitabine-observation-jama-2007/), [Alliance N0574: radiosurgery alone versus radiosurgery plus whole-brain radiotherapy for one to three brain metastases](https://onco.cc/key-papers/paper-alliance-n0574-brown-jama-2016/), [ANBL0532: tandem versus single autologous stem cell transplant for high-risk neuroblastoma](https://onco.cc/key-papers/paper-anbl0532-tandem-transplant-park-jama-2019/), [Association Between Inherited Germline Mutations in Cancer Predisposition Genes and Risk of Pancreatic Cancer](https://onco.cc/key-papers/paper-hu-germline-mutations-pancreatic-cancer-risk-jama-2018/), [Association of Bariatric Surgery With Cancer Risk and Mortality in Adults With Obesity](https://onco.cc/key-papers/paper-aminian-jama/), [Basch: asking patients to report symptoms online during chemotherapy improved survival](https://onco.cc/key-papers/paper-basch-epro-survival-jama-2017/), [Breast cancer following radiotherapy and chemotherapy among young women with Hodgkin disease](https://onco.cc/key-papers/paper-travis-breast-cancer-after-hodgkin-radiotherapy-jama-2003/), [Clinical validation of a circulating tumor DNA-based blood test to screen for colorectal cancer (PREEMPT CRC)](https://onco.cc/key-papers/paper-preempt-crc-shaukat-jama-2025/), [Comparison of Abbreviated Breast MRI vs Digital Breast Tomosynthesis for Breast Cancer Detection Among Women With Dense Breasts Undergoing Screening](https://onco.cc/key-papers/paper-comstock-jama/), [CONKO-001: adjuvant gemcitabine and long-term outcomes after resected pancreatic cancer](https://onco.cc/key-papers/paper-conko-001-adjuvant-gemcitabine-long-term-oettle-jama-2013/), [D'Amico risk groups: biochemical outcome after radical prostatectomy, external beam radiotherapy or brachytherapy](https://onco.cc/key-papers/paper-damico-risk-groups-jama-1998/), [Effect of 3 to 5 years of scheduled CEA and CT follow-up to detect recurrence of colorectal cancer: the FACS randomized clinical trial](https://onco.cc/key-papers/paper-primrose-jama/), [Effect of adjuvant chemotherapy with fluorouracil plus folinic acid or gemcitabine vs observation on survival in patients with resected periampullary adenocarcinoma: the ESPAC-3 periampullary cancer randomized trial](https://onco.cc/key-papers/paper-neoptolemos-jama/), [Effect of Electronic Symptom Monitoring on Patient-Reported Outcomes Among Patients With Metastatic Cancer: A Randomized Clinical Trial](https://onco.cc/key-papers/paper-basch-jama/), [Effect of first-line chemotherapy combined with cetuximab or bevacizumab on overall survival in KRAS wild-type advanced or metastatic colorectal cancer (CALGB/SWOG 80405)](https://onco.cc/key-papers/paper-venook-calgb-80405-cetuximab-vs-bevacizumab-jama-2017/), [Effect of First-Line Serplulimab vs Placebo Added to Chemotherapy on Survival in Patients With Extensive-Stage Small Cell Lung Cancer: The ASTRUM-005 Randomized Clinical Trial](https://onco.cc/key-papers/paper-astrum-005-jama-2022/), [Effect of High-Dose vs Standard-Dose Vitamin D3 Supplementation on Progression-Free Survival Among Patients With Advanced or Metastatic Colorectal Cancer: The SUNSHINE Randomized Clinical Trial](https://onco.cc/key-papers/paper-ng-jama/), [Effect of Metformin vs Placebo on Invasive Disease-Free Survival in Patients With Breast Cancer: The MA.32 Randomized Clinical Trial](https://onco.cc/key-papers/paper-goodwin-jama/), [Effect of Single-Fraction vs Multifraction Radiotherapy on Ambulatory Status Among Patients With Spinal Canal Compression From Metastatic Cancer: The SCORAD Randomized Clinical Trial](https://onco.cc/key-papers/paper-hoskin-jama/), [Effect of Tumor-Treating Fields Plus Maintenance Temozolomide vs Maintenance Temozolomide Alone on Survival in Patients With Glioblastoma: A Randomized Clinical Trial](https://onco.cc/key-papers/paper-stupp-jama/), [ESPAC-3: adjuvant fluorouracil plus folinic acid versus gemcitabine after pancreatic cancer resection](https://onco.cc/key-papers/paper-espac-3-fluorouracil-vs-gemcitabine-adjuvant-neoptolemos-jama-2010/), [Estimated Projection of US Cancer Incidence and Death to 2040](https://onco.cc/key-papers/paper-rahib-projection-us-cancer-2040-jama-netw-open-2021/), [Estimated Research and Development Investment Needed to Bring a New Medicine to Market, 2009-2018](https://onco.cc/key-papers/paper-wouters-jama/), [Identification of Lynch syndrome among patients with colorectal cancer](https://onco.cc/key-papers/paper-moreira-lynch-syndrome-identification-jama-2012/), [Influence of a diet very high in vegetables, fruit, and fiber and low in fat on prognosis following treatment for breast cancer: the Women's Healthy Eating and Living (WHEL) randomized trial](https://onco.cc/key-papers/paper-whel-jama-2007/), [Ivonescimab Plus Chemotherapy in Non-Small Cell Lung Cancer With EGFR Variant: A Randomized Clinical Trial](https://onco.cc/key-papers/paper-harmoni-a-jama-2024/), [LAP07: chemoradiotherapy versus continued chemotherapy for locally advanced pancreatic cancer controlled after four months of gemcitabine](https://onco.cc/key-papers/paper-lap07-chemoradiotherapy-locally-advanced-pancreatic-jama-2016/), [Lead, mercury, and arsenic in US- and Indian-manufactured Ayurvedic medicines sold via the Internet](https://onco.cc/key-papers/paper-saper-jama/), [Mediastinoscopy vs endosonography for mediastinal nodal staging of lung cancer: a randomized trial](https://onco.cc/key-papers/paper-annema-jama/), [Panitumumab vs Bevacizumab Added to Standard First-line Chemotherapy and Overall Survival Among Patients With RAS Wild-type, Left-Sided Metastatic Colorectal Cancer: A Randomized Clinical Trial](https://onco.cc/key-papers/paper-paradigm-jama-2023/), [PROSE consortium: preventive surgery lowers cancer and death in BRCA1 and BRCA2 carriers](https://onco.cc/key-papers/paper-brca-risk-reducing-surgery-jama-2010/), [Prostate-Specific Antigen Screening and 15-Year Prostate Cancer Mortality: A Secondary Analysis of the CAP Randomized Clinical Trial](https://onco.cc/key-papers/paper-martin-jama/), [Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study](https://onco.cc/key-papers/paper-carey-race-breast-cancer-subtypes-cbcs-jama-2006/), [Red Blood Cell Transfusion: 2023 AABB International Guidelines](https://onco.cc/key-papers/paper-carson-jama/), [Risk-Based vs Annual Breast Cancer Screening: The WISDOM Randomized Clinical Trial](https://onco.cc/key-papers/paper-wisdom-trial-jama-2026/), [SCALP: scalp cooling to prevent hair loss during chemotherapy for early breast cancer](https://onco.cc/key-papers/paper-scalp-trial-jama-2017/), [Screening by chest radiograph and lung cancer mortality: the Prostate, Lung, Colorectal, and Ovarian (PLCO) randomized trial](https://onco.cc/key-papers/paper-plco-chest-radiograph-lung-cancer-mortality-jama-2011/), [Screening for Lung Cancer: US Preventive Services Task Force Recommendation Statement](https://onco.cc/key-papers/paper-uspstf-lung-cancer-screening-jama-2021/), [Selumetinib Plus Docetaxel Compared With Docetaxel Alone and Progression-Free Survival in Patients With KRAS-Mutant Advanced Non-Small Cell Lung Cancer: The SELECT-1 Randomized Clinical Trial](https://onco.cc/key-papers/paper-nct01933932-jama-2017/), [Sintilimab Plus Chemotherapy for Unresectable Gastric or Gastroesophageal Junction Cancer: The ORIENT-16 Randomized Clinical Trial](https://onco.cc/key-papers/paper-xu-jama/), [SSG XVIII/AIO: one versus three years of adjuvant imatinib for operable gastrointestinal stromal tumour](https://onco.cc/key-papers/paper-ssg-xviii-adjuvant-imatinib-joensuu-jama-2012/), [Telehealth vs In-Person Early Palliative Care for Patients With Advanced Lung Cancer: A Multisite Randomized Clinical Trial](https://onco.cc/key-papers/paper-greer-jama/), [Tobacco smoking as a possible etiologic factor in bronchiogenic carcinoma; a study of 684 proved cases](https://onco.cc/key-papers/paper-wynder-graham-tobacco-bronchiogenic-carcinoma-jama-1950/), [Toripalimab Plus Chemotherapy for Recurrent or Metastatic Nasopharyngeal Carcinoma: The JUPITER-02 Randomized Clinical Trial](https://onco.cc/key-papers/paper-mai-jama/), [Tumor-Infiltrating Lymphocytes in Triple-Negative Breast Cancer](https://onco.cc/key-papers/paper-leon-ferre-tils-tnbc-no-chemotherapy-jama-2024/), [US Preventive Services Task Force recommendation: colorectal cancer screening from age 45](https://onco.cc/key-papers/paper-uspstf-crc-screening-45-jama-2021/), [Using multiplexed assays of oncogenic drivers in lung cancers to select targeted drugs](https://onco.cc/key-papers/paper-kris-lung-cancer-mutation-consortium-jama-2014/), [USPSTF 2018: screening for prostate cancer, recommendation statement (grade C at 55 to 69, grade D at 70 and over)](https://onco.cc/key-papers/paper-uspstf-prostate-screening-jama-2018/)
- people: [Boris C. Pasche](https://onco.cc/people/boris-pasche/), [Carla van Gils](https://onco.cc/people/carla-van-gils/), [Joseph S. Ross](https://onco.cc/people/joseph-ross/), [Lin Tongyu](https://onco.cc/people/lin-tongyu/)

---
JSON: https://onco.cc/api/v1/entities/jama.json